title: Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus.
abstract: A new species of Ebolavirus, Bundibugyo ebolavirus, was discovered in an outbreak in western Uganda in November 2007. To study the correlation between fatal infection and immune response in Bundibugyo ebolavirus infection, viral antigen, antibodies, and 17 soluble factors important for innate immunity were examined in 44 patient samples. Using Luminex assays, we found that fatal infection was associated with high levels of viral antigen, low levels of pro-inflammatory cytokines, such as IL-1α, IL-1β, IL-6, TNF-α, and high levels of immunosuppressor cytokines like IL-10. Also, acute infected patients died in spite of generating high levels of antibodies against the virus. Thus, our results imply that disease severity in these patients is not due to the multi-organ failure and septic shock caused by a flood of inflammatory cytokines, as seen in infections with other Ebolavirus species.
authors.affiliation: Viral Special Pathogens Branch, NCEZID, DHCPP, Centers for Disease Control and Prevention, Atlanta, GA 30033, USA. mgupta@cdc.gov
authors.forename: Manisha
authors.initials: M
authors.lastname: Gupta
authors.forename: Adam
authors.initials: A
authors.lastname: MacNeil
authors.forename: Zachary D
authors.initials: ZD
authors.lastname: Reed
authors.forename: Pierre E
authors.initials: PE
authors.lastname: Rollin
authors.forename: Christina F
authors.initials: CF
authors.lastname: Spiropoulou
mesh_terms: D000914:Antibodies, Viral / Q000276:immunology*; D000956:Antigens, Viral / Q000276:immunology; D016207:Cytokines / Q000276:immunology*; D004196:Disease Outbreaks; D029043:Ebolavirus / Q000276:immunology* / Q000302:isolation & purification; D019142:Hemorrhagic Fever, Ebola / Q000453:epidemiology / Q000276:immunology* / Q000821:virology; D006801:Humans; D012698:Serologic Tests; D014454:Uganda / Q000453:epidemiology
chemical_list: D000914:Antibodies, Viral; D000956:Antigens, Viral; D016207:Cytokines